Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

PTIX Protagenic Therapeutics

Watchlist
0.5200.0000.00%
Close  12/06 16:00 ET
High
0.534
Open
0.530
Turnover
17.53K
Low
0.520
Pre Close
0.520
Volume
33.58K
Market Cap
8.99M
P/E(TTM)
Loss
52wk High
1.800
Shares
17.29M
P/E(Static)
Loss
52wk Low
0.520
Float Cap
6.58M
Bid/Ask %
-96.08%
Historical High
4.890
Shs Float
12.66M
Volume Ratio
1.84
Historical Low
0.520
Dividend TTM
--
Div Yield TTM
--
P/B
1.22
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.27%
Amplitude
2.75%
Avg Price
0.521
Lot Size
1
Float Cap
6.58M
Bid/Ask %
-96.08%
Historical High
4.890
Shs Float
12.66M
Volume Ratio
1.84
Historical Low
0.520
Dividend TTM
--
P/B
1.22
Dividend LFY
--
Turnover Ratio
0.27%
Amplitude
2.75%
Avg Price
0.521
Lot Size
1
Price Forecast

News

Comment

No Data

Company Overview More
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
CEO: Dr. Garo H. Armen, Pd.D
Market: NASDAQ
Listing Date: 04/27/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist